Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48.8M Buy
406,087
+48,579
+14% +$5.61M 0.26% 75
2025
Q4
$37.6M Buy
357,508
+20,852
+6% +$1.96M 0.21% 93
2025
Q3
$28.3M Sell
336,656
-4,006
-1% -$330K 0.16% 129
2025
Q2
$27M Sell
340,662
-47,329
-12% -$3.76M 0.17% 128
2025
Q1
$34.8M Sell
387,991
-62,615
-14% -$5.85M 0.24% 84
2024
Q4
$44.6M Sell
450,606
-23,138
-5% -$2.39M 0.28% 68
2024
Q3
$47M Buy
473,744
+6,855
+1% +$814K 0.3% 60
2024
Q2
$61.3M Buy
+466,889
New +$60.1M 0.44% 41

Other funds holding MRK

Sanctuary Advisors's MRK Position: Q1 2026 in Review

Sanctuary Advisors increased its Merck (MRK) stake by 14% in Q1 2026, buying an estimated $5.61M and bringing the position to 406,087 shares worth $48.8M. The position accounts for 0.26% of the portfolio, ranked #75.

Sanctuary Advisors first reported a position in MRK in Q2 2024 and has held it in 8 quarters since. The position peaked at $61.3M in Q2 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Sanctuary Advisors held 406,087 shares of Merck worth $48.8M as of Q1 2026.
  • Sanctuary Advisors bought 48,579 Merck shares in Q1 2026, an estimated $5.61M.
  • Merck made up 0.26% of Sanctuary Advisors's portfolio in Q1 2026, its #75 holding.
  • Sanctuary Advisors first reported a position in Merck in Q2 2024 and has held it in 8 quarters since.
  • Sanctuary Advisors's Merck position peaked at $61.3M in Q2 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.